← Back
$TNXP All transactions

Tonix Pharmaceuticals Holding Corp.

▲ BUY
9 / 10

Conviction

$ Value

$63K

Shares

5,000

Price

$13

Filed

Apr 1

Why this score? (9/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

LEDERMAN SETH

Title

Chief Executive Officer

CIK

0001563420

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-31

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

20,001

Footnotes

Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $12.5699 to $12.625 per share. The Reporting Persons undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. | Reporting person may be deemed a control person of this entity.

Filing Info

Accession No.

0001999371-26-007447

Form Type

4

Issuer CIK

0001430306

LEDERMAN SETH's History

Date Ticker Type Value
2026-03-31 TNXP $63K
2026-03-18 TNXP $223K
2026-02-24 TNXP A $0
2026-02-24 TNXP A $0
2025-05-15 TNXP $86K

Other Insiders at TNXP (90d)

Insider Bought Sold Last
LEDERMAN SETH
Chief Executive Officer
$223K 2026-03-18
SULLIVAN GREGORY M
Chief Medical Officer
2026-02-24
MORRIS JESSICA EDGAR
Chief Operating Officer
2026-02-24
SAENGER BRADLEY
Chief Financial Officer
2026-02-24
Fogarty Siobhan
Chief Technology Officer
2026-02-24